1. Home
  2. JAGX vs HYFM Comparison

JAGX vs HYFM Comparison

Compare JAGX & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.60

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

HOLD

Current Price

$0.98

Market Cap

4.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
HYFM
Founded
2013
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
4.4M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
JAGX
HYFM
Price
$0.60
$0.98
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
173.3K
248.2K
Earning Date
04-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
$134,252,000.00
Revenue This Year
$61.58
$57.44
Revenue Next Year
N/A
$5.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.50
52 Week High
$8.00
$3.69

Technical Indicators

Market Signals
Indicator
JAGX
HYFM
Relative Strength Index (RSI) 28.51 48.65
Support Level $0.60 $0.85
Resistance Level $1.04 $1.33
Average True Range (ATR) 0.10 0.15
MACD 0.02 -0.03
Stochastic Oscillator 2.47 39.38

Price Performance

Historical Comparison
JAGX
HYFM

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

Share on Social Networks: